98 related articles for article (PubMed ID: 9434265)
1. L-DOPA cyclohexyl ester is a novel stable and potent competitive antagonist against L-DOPA, as compared to L-DOPA methyl ester.
Misu Y; Goshima Y; Miyamae T; Furukawa N; Sugiyama Y; Okumura Y; Shimizu M; Ohshima E; Suzuki F
Jpn J Pharmacol; 1997 Nov; 75(3):307-9. PubMed ID: 9434265
[TBL] [Abstract][Full Text] [Related]
2. [Studies on novel, stable and potent competitive antagonists against L-DOPA].
Misu Y; Goshima Y; Miyamae T; Furukawa N; Okumura Y; Sugiyama Y; Shimizu M
Nihon Yakurigaku Zasshi; 1997 Oct; 110 Suppl 1():159P-164P. PubMed ID: 9503425
[TBL] [Abstract][Full Text] [Related]
3. DOPA cyclohexyl ester, a DOPA antagonist, blocks the depressor responses elicited by microinjections of nicotine into the nucleus tractus solitarii of rats.
Murota Y; Fujii M; Sugiyama Y; Funabashi T; Yagami T; Takahashi T; Goshima Y
Neurosci Lett; 2008 Sep; 442(2):114-7. PubMed ID: 18620021
[TBL] [Abstract][Full Text] [Related]
4. L-DOPA cyclohexyl ester is a novel potent and relatively stable competitive antagonist against L-DOPA among several L-DOPA ester compounds.
Furukawa N; Goshima Y; Miyamae T; Sugiyama Y; Shimizu M; Ohshima E; Suzuki F; Arai N; Fujita K; Misu Y
Jpn J Pharmacol; 2000 Jan; 82(1):40-7. PubMed ID: 10874587
[TBL] [Abstract][Full Text] [Related]
5. L-dihydroxyphenylalanine methyl ester is a potent competitive antagonist of the L-dihydroxyphenylalanine-induced facilitation of the evoked release of endogenous norepinephrine from rat hypothalamic slices.
Goshima Y; Nakamura S; Misu Y
J Pharmacol Exp Ther; 1991 Aug; 258(2):466-71. PubMed ID: 1865350
[TBL] [Abstract][Full Text] [Related]
6. L-dopaergic components in the caudal ventrolateral medulla in baroreflex neurotransmission.
Miyamae T; Goshima Y; Yue JL; Misu Y
Neuroscience; 1999; 92(1):137-49. PubMed ID: 10392837
[TBL] [Abstract][Full Text] [Related]
7. In vivo antagonism of the behavioral responses to L-3-,4-dihydroxyphenylalanine by L-3-,4-dihydroxyphenylalanine cyclohexyl ester in conscious rats.
Matsushita N; Misu Y; Goshima Y
Eur J Pharmacol; 2009 Mar; 605(1-3):109-13. PubMed ID: 19168057
[TBL] [Abstract][Full Text] [Related]
8. Depressor action of L-threo-dihydroxyphenylserine in the rat nucleus tractus solitarii.
Miyamae T; Yue JL; Goshima Y; Misu Y
Eur J Pharmacol; 1996 Apr; 300(1-2):105-8. PubMed ID: 8741173
[TBL] [Abstract][Full Text] [Related]
9. Baroreceptor-aortic nerve-mediated release of endogenous L-3,4-dihydroxyphenylalanine and its tonic depressor function in the nucleus tractus solitarii of rats.
Yue JL; Okamura H; Goshima Y; Nakamura S; Geffard M; Misu Y
Neuroscience; 1994 Sep; 62(1):145-61. PubMed ID: 7816196
[TBL] [Abstract][Full Text] [Related]
10. GABA may function tonically via GABA(A) receptors to inhibit hypotension and bradycardia by L-DOPA microinjected into depressor sites of the nucleus tractus solitarii in anesthetized rats.
Honjo K; Goshima Y; Miyamae T; Misu Y
Neurosci Lett; 1999 Feb; 261(1-2):93-6. PubMed ID: 10081935
[TBL] [Abstract][Full Text] [Related]
11. Evidence for L-dopa systems responsible for cardiovascular control in the nucleus tractus solitarii of the rat.
Kubo T; Yue JL; Goshima Y; Nakamura S; Misu Y
Neurosci Lett; 1992 Jun; 140(2):153-6. PubMed ID: 1501771
[TBL] [Abstract][Full Text] [Related]
12. An L-DOPA-like depressor action of L-threo-dihydroxyphenyl-serine in the rat caudal ventrolateral medulla.
Furukawa N; Goshima Y; Miyamae T; Nishihama M; Okumura F; Fujita K; Misu Y
Life Sci; 1997; 61(12):1177-83. PubMed ID: 9315508
[TBL] [Abstract][Full Text] [Related]
13. Review on the relationship between nicotinic acetylcholine receptors and dopaminergic neurotransmission in the central nervous system--dopa is an endogenous neuroactive substance.
Misu Y; Nakamura S; Goshima Y; Yue JL; Miyamae T; Kubo T
Yakubutsu Seishin Kodo; 1993 Jun; 13(3):199-210. PubMed ID: 8237136
[TBL] [Abstract][Full Text] [Related]
14. The novel adenosine A2a receptor antagonist ST1535 potentiates the effects of a threshold dose of L-DOPA in MPTP treated common marmosets.
Rose S; Jackson MJ; Smith LA; Stockwell K; Johnson L; Carminati P; Jenner P
Eur J Pharmacol; 2006 Sep; 546(1-3):82-7. PubMed ID: 16925991
[TBL] [Abstract][Full Text] [Related]
15. L-dopa methyl ester antagonizes competitively L-dopa-induced facilitation of noradrenaline release from rat hypothalamic slices.
Goshima Y; Nakamura S; Misu Y
Jpn J Pharmacol; 1990 Jan; 52(1):174-7. PubMed ID: 2308239
[TBL] [Abstract][Full Text] [Related]
16. Evidence for L-dopa relevant to modulation of sympathetic activity in the rostral ventrolateral medulla of rats.
Yue JL; Goshima Y; Miyamae T; Misu Y
Brain Res; 1993 Dec; 629(2):310-4. PubMed ID: 7906602
[TBL] [Abstract][Full Text] [Related]
17. The monoamine reuptake inhibitor BTS 74 398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP-treated primates.
Hansard MJ; Smith LA; Jackson MJ; Cheetham SC; Jenner P
Mov Disord; 2004 Jan; 19(1):15-21. PubMed ID: 14743355
[TBL] [Abstract][Full Text] [Related]
18. In vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats.
Sarre S; Lanza M; Makovec F; Artusi R; Caselli G; Michotte Y
Eur J Pharmacol; 2008 Apr; 584(2-3):297-305. PubMed ID: 18342306
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats.
Tronci E; Simola N; Borsini F; Schintu N; Frau L; Carminati P; Morelli M
Eur J Pharmacol; 2007 Jul; 566(1-3):94-102. PubMed ID: 17445798
[TBL] [Abstract][Full Text] [Related]
20. Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions.
Kääriäinen TM; García-Horsman JA; Piltonen M; Huotari M; Männistö PT
Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):300-7. PubMed ID: 17973898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
